SEC Form 4 · accession 0001574774-18-000001
BIOTELEMETRY, INC. · BEAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred Broadway
Officer — President BioTel Heart
Period of report
Feb 14, 2018
Accepted (ET)
Feb 16, 2018 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001574774
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 14, 2018 | A | 3,635 | $0.00 | A | 29,055 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $33.35 | Feb 14, 2018 | A | 8,653 | A | — | Feb 14, 2028 | Common Stock | 8,653 | 8,653 | D |
Explanation of responses
- F1Represents shares of the Issuer's common stock underlying restricted stock units (RSUs) awarded to the Reporting Person. The RSUs will vest in full on the third anniversary of the grant date, subject to accelerated vesting upon certain terminations of employment following certain corporate transactions involving the Issuer. The shares of common stock underlying the RSUs will be issued when the RSUs vest.
- F2The options shall vest in equal amounts on each of the first four anniversaries of the grant date, provided that the option holder remains in continuous service through the applicable vesting date.